This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Advancements in Cancer Management

Advancements in Cancer Management

Format

Slide Lecture Series

Time to Complete

3.25 hours

Released

June 28, 2019

Expires

June 28, 2020
Add to Queue


Maximum Credits

3.25 / AMA PRA Category 1 CreditsTM

Accredited Provider



This activity is provided by Academy for Continued Healthcare Learning.

Sponsors

This activity is sponsored by Cancer Treatment Centers of America® and ACHL.

Program Description

Advancements in Cancer Management highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as screening high-risk patients, cancer pain management, immunotherapy treatment and adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment, and drug-drug interactions.

Agenda

Updates in Immuno-Oncology in 2019: Is the Checkpoint a Checkmate?
Ankur Parikh, DO

Challenges of Managing Cancer Pain
Vivek Iyer, MD

Integrative Oncology: What Is It and Can It Help Your Patients?
Lorenzo Cohen, PhD

How to Deal with a Radiology “Hedge”
Timothy McCay, DO

Diagnostic Approaches to Pleural Effusions
Larry Ladi,MD, FCCP

Intended Audience

Advancements in Cancer Management is designed to meet the educational needs of primary care providers and specialists involved in the care of patients with cancer.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Explain the use of multimodal analgesia to manage pain and reduce the use of opioids.
  • Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of patients with cancer.
  • Evaluate immuno-oncology approaches in cancer treatment, including patient selection.
  • Describe the appropriate follow-up protocols for identification of pulmonary nodules.
  • Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions.
  • Describe the various treatment options for each of the various pleural effusions.

Conflict Of Interest Disclosure Policy

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commerical services discussed in an educational presentation and (2) with any commerical cupports of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Faculty

Kevin Tulipana, DO, FHM (Course Chair)
Director of Hospital Medicine
Vice Chief of Staff
Cancer Treatment Centers of America
Tulsa, OK

Dr. Tulipana has no relevant financial relationships to disclose.

Stephen Lynch, MD (Course Co-Chair)
Primary Care/Intake Physician
Vice Chief of Staff
Cancer Treatment Centers of America
Phoenix, AZ

Dr. Lynch has no relevant financial relationships to disclose.

Lorenzo Cohen, PhD
Richard E. Haynes Distinguished Professor in Clinical Cancer Prevention
Director of Integrative Medicine
University of Texas MD Anderson Cancer Center
Houston, TX

Dr. Cohen discloses the following:
Consultant: Cancer Treatment Centers of America

Vivek Iyer, MD
Medical Director of Pain Management; Interventional Pain Management Specialist
Cancer Treatment Centers of America
Phoenix, AZ

Dr. Iyer discloses the following:
Consultant: Avanos Medical

Larry Ladi, MD, FCCP
Intensivist
Cancer Treatment Centers of America
Tulsa, OK

Dr. Ladi has no relevant financial relationships to disclose.

Timothy McCay, DO
Medical Director of Imaging & Radiologist
Cancer Treatment Centers of America
Tulsa, OK

Dr. McCay has no relevant financial relationships to disclose.

Ankur Parikh, DO
Medical Director, Precision Medicine
Hematologist/Medical Oncologist
Cancer Treatment Centers of America
Philadelphia, PA

Dr. Parikh has no relevant financial relationships to disclose.

Accredited Provider Disclosures

ACHL and CTCA staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Credit

3.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America (CTCA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 3.25 AMA PRA Category 1 CreditsTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Part II Points

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Advancements in Cancer Management has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Anesthesiology
Family Medicine
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Preventive Medicine
Psychiatry & Neurology
Radiology

Disclosure of Unlabeled Use

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Disclaimer

The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Instructions

This activity will take approximately 3 hours and 15 minutes to complete all 5 chapters. Participants can choose which chapters to view and attest to the appropriate amount of credit for each chapter viewed. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

If you have any questions relating to the accreditation of this activity, please contact:
Vanessa Senatore
Senior Program Director
vsenatore@achlcme.org

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue